{"id":763570,"date":"2023-06-14T07:18:03","date_gmt":"2023-06-14T11:18:03","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/"},"modified":"2023-06-14T07:18:03","modified_gmt":"2023-06-14T11:18:03","slug":"monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/","title":{"rendered":"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">WILMETTE, Ill., June  14, 2023  (GLOBE NEWSWIRE) &#8212; Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that Chandler Robinson, MD, Monopar\u2019s Chief Executive Officer, will participate in a one-on-one fireside chat with Jason McCarthy, PhD, Senior Managing Director of Equity Research, at the Maxim Group\u2019s Healthcare Virtual Conference on Tuesday June 20, 2023 at 1:30pm ET.<\/p>\n<p>\n        <strong><br \/>\n          <em>Fireside Chat Details:<br \/><\/em><br \/>\n        <\/strong>Date: June 20, 2023<br \/>Time: 1:30 pm ET<br \/>Location: Virtual Conference<\/p>\n<p>\n        <strong>About Monopar Therapeutics Inc.<\/strong>\n      <\/p>\n<p>Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients. Monopar&#8217;s pipeline consists of camsirubicin (Phase 1b) for the treatment of advanced soft tissue sarcoma\u037e MNPR-101, a late-stage preclinical antibody for radiopharmaceutical use in advanced cancers\u037e and MNPR-202, an early-stage camsirubicin analog for various cancers. For more information, visit:\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=moIh1lm-y6tf6oijIDHx-6wG7jyUaOodn77gufy4In44ICxE5GuRN2gdExpuTo9qSENKNlcayipRZ8Fh_imelUORMkCaJjbqLe1B4fdJ8q74PsvXmuemqgdCcpGWXUldXc441D3ossv0GtFmSUSr72Y4dhIfLWynMIyN5TDrIdde9trfhMuuavOGldp3CPt3YBsZUKx0ITamBiUDZWhdUk1DRBZLrpHhFdzpDne12wuZTroNCcf4cRCjqAfhudNW2rAhmz49pCB8ZK2RjuWo6TqTaQAGK9kWNgCp18NOez6Odbc-IhU2Uum8Fot-wFBaxc9FVSunUaT8qilpbhz6ob_o_qogRa_-1NN9tAEyVtGQcXRSDKh8AaPh56c9HgBqRrmIDC9Wh6XbqBdQOjGx4vg1tVl-qU8ygJYjsPYrOUM=\" rel=\"nofollow noopener\" target=\"_blank\">www.monopartx.com<\/a>.<\/p>\n<p>\n        <strong>CONTACT:<\/strong>\u2009\u2009<\/p>\n<p>\n        <strong>Monopar Therapeutics Inc.<\/strong><br \/>\n        <br \/>Investor Relations\u2009\u2009 <br \/>Kim R. Tsuchimoto\u2009\u2009 <br \/>Chief Financial Officer\u2009\u2009 <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NDLq182biI5NDeP9HQMMpB7fzSf4zny20fjC6f9nyAYEdBe9liKkJpyqXzzlTyTMcPX6s-XJlPsMV73upiWeXqDCR14er9F4bTaAAHhsfNt6Vy6l9G7F387xVIgB86MX9VeyAvd6ntt_EHcpkF8JZUt56JgvkWRM3TcEouIvHy-0miO9e3ibzFi4iisXd3532mxf6pvw9LQGZbZhjGV0rrNpdc573uyPlz2DO73RHiEqeR-w66oxWhoPLzwqps-oHABJAjI_7JTLfabsBeUIGw==\" rel=\"nofollow noopener\" target=\"_blank\"><u>kimtsu@monopartx.com<\/u><\/a><\/p>\n<p>Follow Monopar on social media for updates:\u2009 <br \/>Twitter: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A5tDiXGRPFJrPzNDxVbEFIsZjTU3iP30LK1lTqqPCHqKOAirkCGRYDMTCKKq_ER7fFGL5RVApQqlDrmmrItwHFKkck0v_IA9CHOZAcX50wKqYH_cgYzlU-HcYAXyH8LG5UUrMPecgi_RFZwVKyTKl2G1qqbXrBXZRMdwvR9VMIwHZaXmAHyKtcIYbr0g6P5ftkqDqVLRV3SUArL8dSJ-7BVs_AIUw3ERF8vLP7s626w=\" rel=\"nofollow noopener\" target=\"_blank\"><u>@MonoparTx<\/u><\/a>\u2009 LinkedIn: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=nl4V_OF1uckCL9P3pHN_abqoXB3muHSabH9f9LnRvGoRbTiA6TjFhSVR2EWypoyFXXZcMqbr8po3AbiT8JW-bZl7tKRzsNQ_ZT7b4GZn9WFTxPUwpng1D0zIAFv0Twq9WLiSq4CVRFMKAgkVW4ywW3aAB0qaqcHH4awY8-Bxsii1c3iNctWOAbOG2kV4GaqpWR3u3j8whILKKtHRlVwVEsPQM7cZF7SYOWSAfCHjqHZ5HB3YyB4glRetG2tGGFOGWvZOMqVPxWCpG9zh25T5i9VaDok2JOXPq9h-yPKffmwsPveCt8TNOa_PFzAsDMEb\" rel=\"nofollow noopener\" target=\"_blank\"><u>Monopar Therapeutics<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/NTBkNWRjYWItYmE1MC00MTEwLWIyZDctZGQxYmIwZjQ2YjBhLTEyMDU0MTY=\/tiny\/Monopar-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>WILMETTE, Ill., June 14, 2023 (GLOBE NEWSWIRE) &#8212; Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that Chandler Robinson, MD, Monopar\u2019s Chief Executive Officer, will participate in a one-on-one fireside chat with Jason McCarthy, PhD, Senior Managing Director of Equity Research, at the Maxim Group\u2019s Healthcare Virtual Conference on Tuesday June 20, 2023 at 1:30pm ET. Fireside Chat Details: Date: June 20, 2023Time: 1:30 pm ETLocation: Virtual Conference About Monopar Therapeutics Inc. Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients. Monopar&#8217;s pipeline consists of camsirubicin (Phase 1b) for the treatment of advanced soft tissue sarcoma\u037e MNPR-101, a late-stage preclinical antibody for radiopharmaceutical &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-763570","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"WILMETTE, Ill., June 14, 2023 (GLOBE NEWSWIRE) &#8212; Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that Chandler Robinson, MD, Monopar\u2019s Chief Executive Officer, will participate in a one-on-one fireside chat with Jason McCarthy, PhD, Senior Managing Director of Equity Research, at the Maxim Group\u2019s Healthcare Virtual Conference on Tuesday June 20, 2023 at 1:30pm ET. Fireside Chat Details: Date: June 20, 2023Time: 1:30 pm ETLocation: Virtual Conference About Monopar Therapeutics Inc. Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients. Monopar&#8217;s pipeline consists of camsirubicin (Phase 1b) for the treatment of advanced soft tissue sarcoma\u037e MNPR-101, a late-stage preclinical antibody for radiopharmaceutical &hellip; Continue reading &quot;Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-14T11:18:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference\",\"datePublished\":\"2023-06-14T11:18:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/\"},\"wordCount\":174,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/\",\"name\":\"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=\",\"datePublished\":\"2023-06-14T11:18:03+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/","og_locale":"en_US","og_type":"article","og_title":"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference - Market Newsdesk","og_description":"WILMETTE, Ill., June 14, 2023 (GLOBE NEWSWIRE) &#8212; Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today announced that Chandler Robinson, MD, Monopar\u2019s Chief Executive Officer, will participate in a one-on-one fireside chat with Jason McCarthy, PhD, Senior Managing Director of Equity Research, at the Maxim Group\u2019s Healthcare Virtual Conference on Tuesday June 20, 2023 at 1:30pm ET. Fireside Chat Details: Date: June 20, 2023Time: 1:30 pm ETLocation: Virtual Conference About Monopar Therapeutics Inc. Monopar Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients. Monopar&#8217;s pipeline consists of camsirubicin (Phase 1b) for the treatment of advanced soft tissue sarcoma\u037e MNPR-101, a late-stage preclinical antibody for radiopharmaceutical &hellip; Continue reading \"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-14T11:18:03+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference","datePublished":"2023-06-14T11:18:03+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/"},"wordCount":174,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/","name":"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=","datePublished":"2023-06-14T11:18:03+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODg1Nzg4MCM1NjQ2NTQyIzIxOTM4NjM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/monopar-to-participate-in-the-maxim-groups-healthcare-virtual-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Monopar to Participate in the Maxim Group\u2019s Healthcare Virtual Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/763570","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=763570"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/763570\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=763570"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=763570"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=763570"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}